SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001193125-22-084189
Filing Date
2022-03-25
Accepted
2022-03-24 20:02:54
Documents
6

Document Format Files

Seq Description Document Type Size
1 424B5 d338893d424b5.htm 424B5 437746
2 EX-FILING FEES d338893dexfilingfees.htm EX-FILING FEES 14462
3 GRAPHIC g338893g05m00.jpg GRAPHIC 121097
4 GRAPHIC g338893g06m00.jpg GRAPHIC 82662
5 GRAPHIC g338893g06u01.jpg GRAPHIC 61653
6 GRAPHIC g338893g37b74.jpg GRAPHIC 33463
  Complete submission text file 0001193125-22-084189.txt   861452
Mailing Address 100 FIFTH AVENUE WALTHAM MA 02451
Business Address 100 FIFTH AVENUE WALTHAM MA 02451 617-977-5700
Apellis Pharmaceuticals, Inc. (Filer) CIK: 0001492422 (see all company filings)

IRS No.: 271537290 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-235830 | Film No.: 22767942
SIC: 2834 Pharmaceutical Preparations